NAD(+)-boosting therapy alleviates nonalcoholic fatty liver disease via stimulating a novel exerkine Fndc5/irisin

por Li, Dong-Jie, Sun, Si-Jia, Fu, Jiang-Tao, Ouyang, Shen-Xi, Zhao, Qin-Jie, Su, Li, Ji, Qing-Xi, Sun, Di-Ynag, Zhu, Jia-Hui, Zhang, Guo-Yan, Ma, Jia-Wei, Lan, Xiu-Ting, Zhao, Yi, Tong, Jie, Li, Guo-Qiang, Shen, Fu-Ming, Wang, Pei
Publicado 2021